BPC-157 is a synthetic pentadecapeptide. Preclinical research has explored growth-factor and nitric-oxide signaling, while human evidence for subcutaneous use remains limited. Available by prescription only after provider review.
From $188 first month
Mechanism education without turning preclinical findings into promises.
BPC-157 is a 15-amino-acid synthetic peptide derived from a partial sequence of a gastric protein. It is not an FDA-approved medication.
Cell and animal studies have explored relationships between BPC-157 and VEGF, EGF, and nitric-oxide signaling. These are mechanistic findings, not proof of healing or recovery benefits in humans.
Small studies have used rectal, intra-articular, intravesical, and intravenous administration. FDA found no studies using the proposed subcutaneous route, and long-term safety and effectiveness remain unestablished.
Your provider reviews your history, medications, and goals before determining whether this compounded injectable option is appropriate and how it should be used.
Prescribed only when a licensed provider determines it is appropriate based on your history, medications, and treatment goals.
When prescribed, your medication is prepared by and shipped directly from a licensed U.S. pharmacy in discreet packaging.
Each product page separates mechanism research from human evidence so the unknowns stay visible.
Message your care team with questions about your protocol, refills, or side effects.
Get started in 4 simple steps. No office visits required.
A 5-minute online health questionnaire, no appointment, no waiting room.
A licensed provider in your state reviews your history and prescribes if appropriate.
When prescribed, your medication ships from a licensed U.S. pharmacy in discreet packaging.
Message your care team anytime. Dose questions and refills are handled online.
Most mechanism research is preclinical. Small human reports use other routes and do not establish subcutaneous effectiveness or long-term safety.
No. This compounded medication is not FDA-approved. Compounded drugs are prepared for individual patients, and FDA does not verify their safety, effectiveness, or quality before marketing.
Complete the online assessment. A licensed provider reviews your medical history, medications, and goals before deciding whether to prescribe.
Current pricing is shown on this page when a customer offer exists. Your provider-directed protocol and any additional details are confirmed during assessment and review.
Your assessment takes about 5 minutes. A licensed provider reviews your information and determines whether treatment is appropriate.
Start Assessment